Philippe Bedard, MD, FRCPC

Follow Dr. Bedard:
Dr. Bedard received his medical degree from the University of Toronto where he was awarded the Cody Academic Silver Medal. He completed his Internal Medicine and Medical Oncology specialty training at the University of Toronto. He received additional fellowship training in clinical and translational breast cancer research at the Breast International Group (BIG).
 
In recognition of his research excellence, Dr. Bedard received the 2012 Career Development Award from the the Conquer Cancer Foundation of the American Society of Clinical Oncology.
Dr. Bedard has a clinical practice and a research program. His clinical practice includes the treatment of patients with breast and testicular cancers. His research program involves early phase clinical trials with novel cancer drug treatments. These emerging treatments include immunotherapy and the personalization of cancer treatment based upon the results of testing for DNA mutations within tumor cells.
 
As a member of the Steering Committee for the AACR-GENIE project, Dr. Bedard is contributing to this international data-sharing initiative, which links cancer genomic data with clinical outcomes from tens of thousands of cancer patients treated at leading international institutions.
Am Soc Clin Oncol Educ Book. 2018 May 23;(38):56-64
Kratz J, Burkard M, O'Meara T, Pusztai L, Veitch Z, Bedard PL
Ann Oncol. 2018 Aug 21;:
Mateo J, Chakravarty D, Dienstmann R, Jezdic S, Gonzalez-Perez A, Lopez-Bigas N, Ng CKY, Bedard PL, Tortora G, Douillard JY, Van Allen EM, Schultz N, Swanton C, André F, Pusztai L
BMC Med Genomics. 2018 Aug 09;11(1):65
Stjepanovic N, Stockley TL, Bedard PL, McCuaig JM, Aronson M, Holter S, Semotiuk K, Leighl NB, Jang R, Krzyzanowska MK, Oza AM, Gupta A, Elser C, Ahmed L, Wang L, Kamel-Reid S, Siu LL, Kim RH
Invest New Drugs. 2018 Aug 03;:
Harding JJ, Bauer TM, Tan DSW, Bedard PL, Rodon J, Doi T, Schnell C, Iyer V, Baffert F, Radhakrishnan R, Fabre C, Juric D
JAMA Oncol. 2018 Jun 28;:
Borges VF, Ferrario C, Aucoin N, Falkson C, Khan Q, Krop I, Welch S, Conlin A, Chaves J, Bedard PL, Chamberlain M, Gray T, Vo A, Hamilton E
Oncotarget. 2018 Apr 27;9(32):22559-22570
Korpanty GJ, Kamel-Reid S, Pintilie M, Hwang DM, Zer A, Liu G, Leighl NB, Feld R, Siu LL, Bedard PL, Tsao MS, Shepherd FA
Clin Cancer Res. 2018 May 23;:
Dickler MN, Saura C, Richards D, Krop I, Cervantes A, Bedard PL, Patel MR, Pusztai L, Oliveira M, Cardenas AK, Cui N, Wilson TR, Stout TJ, Wei MC, Hsu JY, Baselga J
BJU Int. 2018 May 03;:
Lewin J, Soltan Ghoraie L, Bedard PL, Hamilton RJ, Chung P, Moore M, Jewett MAS, Anson-Cartwright L, Virtanen C, Winegarden N, Tsao J, Warde P, Sweet J, Haibe-Kains B, Hansen AR
Clin Cancer Res. 2018 Mar 20;:
Rugo HS, Delord JP, Im SA, Ott PA, Piha-Paul SA, Bedard PL, Sachev J, Le Tourneau C, van Brummelen EMJ, Varga A, Salgado R, Loi S, Saraf S, Pietrangelo D, Karantza V, Tan AR
J Urol. 2018 Feb 20;:
Leão R, van Agthoven T, Figueiredo A, Jewett MAS, Fadaak K, Sweet J, Ahmad AE, Anson-Cartwright L, Chung P, Hansen A, Warde P, Castelo-Branco P, O'Malley M, Bedard PL, Looijenga LHJ, Hamilton RJ

Pages


 

Associate Professor, Faculty of Medicine, University of Toronto
Member, Steering Committee, American Association for Cancer Research (AACR) Genomics, Evidence, Neoplasia, Information, Exchange (GENIE) Project
Staff Medical Oncologist, Division of Medical Oncology, Princess Margaret Cancer Centre
Fellowship Director, Bras Drug Development Program, Princess Margaret Cancer Centre
Clinical Director, Cancer Genomics Program, Princess Margaret Cancer Centre